Multiple biomarkers for mortality prediction in peripheral arterial disease

Vascular Medicine (United Kingdom)

Volumn 21, Issue 2, 2016, Pages 105-112

  Amrock, Stephen M ^a   Weitzman, Michael ^b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

albuminuria; high sensitivity C reactive protein; homocysteine; inflammation; leukocyte; mortality; peripheral artery disease; risk stratification

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; HOMOCYSTEINE;

AGED; ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL LYMPHOCYTE RATIO; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ALBUMINURIA; BLOOD; CAUSE OF DEATH; DECISION SUPPORT SYSTEM; EPIDEMIOLOGY; KAPLAN MEIER METHOD; LYMPHOCYTE; LYMPHOCYTE COUNT; MIDDLE AGED; NEUTROPHIL; NUTRITION; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TIME FACTOR; UNITED STATES; URINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALBUMINURIA; ANKLE BRACHIAL INDEX; BIOMARKERS; C-REACTIVE PROTEIN; CAUSE OF DEATH; CREATININE; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; FEMALE; HOMOCYSTEINE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; NUTRITION SURVEYS; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84961251655     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X15621797     Document Type: Article

References (48)

1. Fowkes FG, Rudan D, Rudan I, et al.Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 2013; 382: 1329-1340.
2. Criqui MH, Langer RD, Fronek A, et al.Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-386.
3. Pande RL, Perlstein TS, Beckman JA, et al.Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation 2011; 124: 17-23.
4. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385: 117-171.
5. Haugen S, Casserly IP, Regensteiner JG, et al.Risk assessment in the patient with established peripheral arterial disease. Vasc Med 2007; 12: 343-350.
6. Brevetti G, Giugliano G, Brevetti L, et al.Inflammation in peripheral artery disease. Circulation 2010; 122: 1862-1875.
7. Ridker PM, Cushman M, Stampfer MJ, et al.Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97: 425-428.
8. Bloemenkamp DG, van den Bosch MA, Mali WP, et al.Novel risk factors for peripheral arterial disease in young women. Am J Med 2002; 113: 462-467.
9. Brevetti G, Oliva G, Silvestro A, et al.Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis 2004; 175: 131-138.
10. Wildman RP, Muntner P, Chen J, et al.Relation of inflammation to peripheral arterial disease in the National Health and Nutrition Examination survey, 1999-2002. Am J Cardiol 2005; 96: 1579-1583.
11. Tzoulaki I, Murray GD, Lee AJ, et al.C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 2005; 112: 976-983.
12. Cassar K, Bachoo P, Ford I, et al.Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg 2005; 29: 171-176.
13. Van Wijk DF, Boekholdt SM, Wareham NJ, et al.C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study. Arterioscler Thromb Vasc Biol 2013; 33: 2888-2894.
14. Ridker PM, Stampfer MJ, Rifai N,. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285: 2481-2485.
15. Vainas T, Stassen FR, de Graaf R, et al.C-reactive protein in peripheral arterial disease: Relation to severity of the disease and to future cardiovascular events. J Vasc Surg 2005; 42: 243-251.
16. Bleda S, De Haro J, Acin F, et al.Inflammatory burden predicts long-term outcomes in endovascular therapy in peripheral arterial disease. Ann Vasc Surg 2013; 27: 459-466.
17. Tamhane UU, Aneja S, Montgomery D, et al.Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008; 102: 653-657.
18. Nunez J, Nunez E, Bodi V, et al.Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008; 101: 747-752.
19. Tokgoz S, Kayrak M, Akpinar Z, et al.Neutrophil lymphocyte ratio as a predictor of stroke. J Stroke Cerebrovasc Dis 2013; 22: 1169-1174.
20. Erturk M, Cakmak HA, Surgit O, et al.The predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease. J Cardiol 2014; 64: 371-376.
21. Spark JI, Laws P, Fitridge R,. The incidence of hyperhomocysteinaemia in vascular patients. Eur J Vasc Endovasc Surg 2003; 26: 558-561.
22. Antoniades C, Antonopoulos AS, Tousoulis D, et al.Homocysteine and coronary atherosclerosis: From folate fortification to the recent clinical trials. Eur Heart J 2009; 30: 6-15.
23. Wattanakit K, Folsom AR, Criqui MH, et al.Albuminuria and peripheral arterial disease: Results from the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 2008; 201: 212-216.
24. Weir MR,. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007; 2 (3): 581-590.
25. Jager A, Kostense PJ, Ruhe HG, et al.Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: Five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-624.
26. Wang TJ, Gona P, Larson MG, et al.Multiple biomarkers and the risk of incident hypertension. Hypertension 2007; 49: 432-438.
27. Wang TJ, Gona P, Larson MG, et al.Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355: 2631-2639.
28. Zipf G, Chiappa M, Porter KS, et al.National Health and Nutrition Examination Survey: Plan and operations, 1999-2010. Vital Health Stat 1 2013; 56: 1-37.
29. Levey AS, Coresh J, Greene T, et al.Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
30. National Center for Health Statistics. Office of Analysis and Epidemiology, National Health and Nutrition Examination Survey (NHANES) 1999-2004 Linked Mortality Files, Mortality follow-up through 2006: Matching Methodology. Hyattsville, MD, 2009.
31. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al.Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172; discussion 207-212.
32. Li DB, Hua Q, Liu Z, et al.Association between inflammatory mediators and angiographic morphologic features indicating thrombus formation in patients with acute myocardial infarction. Chin Med J (Engl) 2009; 122: 1738-1742.
33. Kruk M, Przyluski J, Kalinczuk L, et al.Association of non-specific inflammatory activation with early mortality in patients with ST-elevation acute coronary syndrome treated with primary angioplasty. Circ J 2008; 72: 205-211.
34. Horne BD, Anderson JL, John JM, et al.Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45: 1638-1643.
35. Bhat T, Teli S, Rijal J, et al.Neutrophil to lymphocyte ratio and cardiovascular diseases: A review. Expert Rev Cardiovasc Ther 2013; 11: 55-59.
36. Zhou J, Austin RC,. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms. Biofactors 2009; 35: 120-129.
37. Casas JP, Bautista LE, Smeeth L, et al.Homocysteine and stroke: Evidence on a causal link from mendelian randomisation. Lancet 2005; 365: 224-232.
38. Marti-Carvajal AJ, Sola I, Lathyris D,. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2015; 1: CD006612.
39. Andras A, Stansby G, Hansrani M,. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts. Cochrane Database Syst Rev 2013; 7: CD003285.
40. Khandanpour N, Armon MP, Jennings B, et al.Randomized clinical trial of folate supplementation in patients with peripheral arterial disease. Br J Surg 2009; 96: 990-998.
41. Criqui MH, Ninomiya JK, Wingard DL, et al.Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol 2008; 52: 1736-1742.
42. Jorgensen L, Jenssen T, Johnsen SH, et al.Albuminuria as risk factor for initiation and progression of carotid atherosclerosis in non-diabetic persons: The Tromso Study. Eur Heart J 2007; 28: 363-369.
43. Huang M, Matsushita K, Sang Y, et al.Association of kidney function and albuminuria with prevalent and incident hypertension: The Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis 2015; 65: 58-66.
44. Xu B, Dai M, Li M, et al.Low-grade albuminuria is associated with peripheral artery disease in Chinese diabetic patients. Atherosclerosis 2014; 232: 285-288.
45. Aboyans V, Criqui MH, Denenberg JO, et al.Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 2006; 113: 2623-2629.
46. Valentine RJ, Jackson MR, Modrall JG, et al.The progressive nature of peripheral arterial disease in young adults: A prospective analysis of white men referred to a vascular surgery service. J Vasc Surg 1999; 30: 436-444.
47. Dachun X, Jue L, Liling Z, et al.Sensitivity and specificity of the ankle-brachial index to diagnose peripheral artery disease: A structured review. Vasc Med 2010; 15: 361-369.
48. Kerr KF, McClelland RL, Brown ER, et al.Evaluating the incremental value of new biomarkers with integrated discrimination improvement. Am J Epidemiol 2011; 174: 364-374.